Tr1X
PrivateLast Round
Grant
Jun 25, 2026
Total Funding Raised
$78M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Tr1X is a biotechnology company developing off-the-shelf allogeneic regulatory T cell therapies to treat autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tr1X Comparables
Compare Tr1X with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 87% | |
| Cellenkos, Inc. | 86% | |
| Sonoma Biotherapeutics | 84% |
Tr1X Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 25, 2026 | ||||
| Series B | Oct 14, 2025 | ||||
| Grant | Apr 4, 2025 | ||||
| Grant | Jan 1, 2024 |
Tr1X Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Grant |
| Neva SGR | Grant, Series B |
| The Chernin Group | Grant |
| California Institute for Regenerative Medicine | Grant |
| Alexandria Venture Investments | Grant, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 76% MoM.
- Aug 20, 2026
Monthly visitors increased 35% MoM.
Tr1X Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tr1X's valuation, stock price, and market status.
Is Tr1X a public or private company?
Tr1X is a private company.
What is the current stock price of Tr1X?
Tr1X is a private company, so its shares have no public market price. Caplight tracks Tr1X's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tr1X worth (valuation)?
Valuation information for Tr1X is not publicly available.
Can I buy Tr1X stock?
Tr1X shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tr1X's last funding round?
Tr1X's most recent funding round was Grant on June 25, 2026.
Who are the main investors in Tr1X?
Key investors in Tr1X include The Column Group, The Chernin Group.
Will Tr1X IPO soon?
No public IPO plans have been announced for Tr1X.
How can I track Tr1X secondary market activity?
Caplight tracks bids, offers, and trades in Tr1X's shares on secondary markets.